Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ODX.L Share Price
  4. ODX.L Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksODX.L Regulatory News (ODX)

ODX.L Information
  • There is currently no data for ODX

Director/PDMR Shareholding

30 Jan 2012 11:57

RNS Number : 3889W
Omega Diagnostics Group PLC
30 January 2012
 



 

AIM:ODX

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Director/PDMR Shareholding

 

Omega, the AIM listed medical diagnostics company, announces that Kieron Harbinson, Group Finance Director of the Company, today purchased 90,000 Ordinary Shares of 4p each at a price of 11p. Following this transaction, Mr Harbinson's total holding is 294,150 Ordinary Shares, representing 0.35% of the total issued share capital of the Company.

 

 

Enquiries:

 

Omega Diagnostics Group plc

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

Seymour Pierce Group

Tel: 020 7107 8000

Freddy Crossley / Mark Percy (Corporate Finance)

www.seymourpierce.com

David Banks / Katie Ratner (Corporate Broking)

Walbrook PR Limited

Paul McManus

Tel: 020 7933 8787

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

 

Fiona Henson

Tel: 020 7933 8795

Mob: 07886 335 992

fiona.henson@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBBGDBLUXBGDG
34567891011
Date   Source Headline
22nd May 202012:30 pmRNSExercise of Options and TVR
15th May 202011:05 amRNSSecond Price Monitoring Extn
15th May 202011:00 amRNSPrice Monitoring Extension
13th May 20202:00 pmRNSPrice Monitoring Extension
7th May 20208:15 amRNSExercise of Options and TVR
6th May 202011:00 amRNSPrice Monitoring Extension
4th May 202011:00 amRNSExercise of Options and TVR
1st May 20202:30 pmRNSHolding(s) in Company
1st May 20202:05 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
30th Apr 202012:00 pmRNSExercise of Options and TVR
29th Apr 20205:37 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSHolding(s) in Company
28th Apr 20205:43 pmRNSHolding(s) in Company
28th Apr 20207:00 amRNSVISITECT® CD4 Advanced Disease - supply agreement
27th Apr 20204:42 pmRNSSecond Price Monitoring Extn
27th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20209:06 amRNSSecond Price Monitoring Extn
27th Apr 20209:00 amRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSCE-Mark of COVID-19 ELISA antibody test
24th Apr 202011:00 amRNSPrice Monitoring Extension
20th Apr 20202:05 pmRNSSecond Price Monitoring Extn
20th Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20201:24 pmRNSHolding(s) in Company
20th Apr 20201:23 pmRNSHolding(s) in Company
20th Apr 20207:00 amRNSHolding(s) in Company
20th Apr 20207:00 amRNSCOVID-19 MTA signed with Mologic Ltd
16th Apr 20205:40 pmRNSHolding(s) in Company
16th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 20203:06 pmRNSHolding(s) in Company
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:36 pmRNSPrice Monitoring Extension
9th Apr 20207:00 amRNSCOVID-19 Consortium MOU
6th Apr 20209:30 amRNSVISITECT® CD4 Advanced Disease evaluation
6th Apr 20208:34 amRNSHolding(s) in Company
2nd Apr 20207:00 amRNSChinese Approval for Food Detective® test
2nd Apr 20207:00 amRNSTrading Update
24th Jan 20207:00 amRNSGrant of Options under Company EMI Plan
21st Jan 20203:24 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSExercise of Options and Total Voting Rights
17th Jan 202010:30 amRNSNigerian MOH approval for VISITECT CD4 350 test
8th Jan 202012:13 pmRNSHolding(s) in Company
16th Dec 20194:05 pmRNSDirector/PDMR Shareholding
9th Dec 20194:30 pmRNSHolding(s) in Company
2nd Dec 20199:00 amRNSGrant of Share Options
2nd Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSNigerian order for VISITECT® CD4
25th Nov 20197:00 amRNSUpdate on Allergy test menu
21st Nov 20197:00 amRNSInvestor results briefing
22nd Oct 201911:39 amRNSResult of AGM
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
DPEU
DPEU.L
LSE
0.00%
IMEU
Ishr Msci Eur
LSE
-0.58%
ARCM
Arc Minerals
LSE
0.00%
VSL
Vpc Specialty
LSE
0.00%
THG
Thg
LSE
-4.08%
Trending
BEM
Beowulf Mining PLC
LSE
63.64%
IMM
Immupharma
LSE
-2.26%
CMRS
Critical Mineral Resources PLC
LSE
-4.76%
KEN
Kendrick Resources
LSE
9.84%
PHE
Powerhouse Ener
LSE
4.76%